Actively Recruiting
Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer
Led by Centre Henri Becquerel · Updated on 2025-12-16
10
Participants Needed
1
Research Sites
31 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant Head and neck cancer compared to definitive histological analysis (gold standard).
CONDITIONS
Official Title
Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Adult male or female, aged 18 or older
- Diagnosed with a malignant tumor of the oral cavity, oropharynx, hypopharynx, larynx, sinuses, or salivary glands, operable and any lymph node status (any N) with no distant metastasis (M0)
- Member or beneficiary of a social security plan
You will not qualify if you...
- Child-Pugh C liver failure
- Under guardianship, conservatorship, or legal protection
- Deprived of liberty
- Pregnant or breastfeeding women
- Hypersensitive to 18F-FDG or any excipients such as ethanol or water for injection
- Uncontrolled diabetes
- Moderate to end-stage renal failure (stage IIIB to V) with glomerular filtration rate less than 44 mL/min/1.73 m8
- Unable to understand the study or comply with trial requirements due to language, psychological, or geographical issues
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Henri Becquerel
Rouen, France
Actively Recruiting
Research Team
L
Lise-Marie Roussel, MD
CONTACT
D
Doriane Richard, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here